SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : CMDX - Chemdex, another CMGI gem

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JDAVID38 who wrote (5)7/9/1999 11:07:00 AM
From: William F. Wager, Jr.   of 200
 
Investors...

The Chemdex Corporation's investors, advisors, and sister companies also offer deep experience and
expertise in the Internet and e-commerce as well as the biotechnology and life science industries.

Kleiner Perkins Caufield & Byers
Eugene Kleiner and Thomas Perkins formed America's premier venture capital firm, Kleiner Perkins, in
1972 with the goal of providing value added resources to entrepreneurs as well as capital investment.
The Kleiner Perkins partnership and the subsequent Kleiner Perkins Caufield & Byers series of
partnerships have created some of the most innovative and rapidly growing businesses of the 20th
century, with assets measured in tens of billions of dollars. Recent life science and Internet
investments include: @Home, Amazon, Netscape, Onsale, Excite, Biosite, CellPro, Cardima,
Pharmacyclics, Argonaut Technologies, Arris Pharmaceuticals, Athena Neurosciences (Elan) and
Pangea Systems..

E.M. Warburg, Pincus & Co., LLC
E.M. Warburg, Pincus & Co., LLC is a major global private equity investment firm managing
approximately $7.5 billion of investments. Headquartered in New York City, the firm also has offices in
London and Hong Kong. Since 1971, the firm has made almost 300 direct equity investments in
startup, developing or expanding, and late stage enterprises with significant long term, global growth
potential. The firm's investments in the life sciences and information technology include Transkaryotic
Therapies, Inc., Synergen, NexStar Pharmaceuticals, United HealthCare Corporation, U.S. HealthCare,
Inc., ValueHealth, Inc., Humana, Inc., CN Biosciences, Inc., Ventana Genetics, Inc., BEA Systems
Inc., Zilog, Inc., Industri-Matematik International Corp., LCI International, Inc., Intuit, Gartner Group,
Inc., Level One Communications, Inc., NOVA Corporation, SHL Systemhouse Inc., EarthWeb, FAME
Information Services, TSI International, and VERITAS Software Corporation.

CMG @Ventures
CMG Information Services, Inc. (NASDAQ:CMGI) invests in and integrates advanced Internet,
interactive media, and database management technologies. Its CMG @Ventures affiliate has invested
in Chemdex and has significant interests in Lycos (NASDAQ:LCOS), Blaxxun, Vicinity, GeoCities,
Parable LLC, Reel.com, PlanetAll, KOZ, Silknet, Speech Machines, and Softway Systems. Both
Microsoft and Intel hold minority positions in CMG Information Services.

Bay City Capital
Bay City Capital LLC is a new merchant banking and management advisory partnership. It was formed
by the Craves Group and the Pritzker Family for investing exclusively in the life sciences industry.
Managing partners include Fred Craves, Chairman of NeoRx and Chairman and CEO of Epoch
Pharmaceuticals; Roger Salquist, Chairman of EndoSonics Corporation and former Chairman of
Calgene; and John Diekman, Chairman of Affymetrix.

K&E Management
K&E Management, Ltd. is the venture capital firm operated by Robert A. Swanson. Mr. Swanson,
generally considered the founding father of the biotechnology industry, is the current Chairman of
biotech startup Tularik, which is pioneering drugs that chemically activate/deactivate genes at the root
of major diseases. Mr. Swanson, a founder of Genentech and its Chief Executive Officer from 1976 to
1990, was Chairman of the Board of Genentech from 1990 to 1996. Prior to forming Genentech, Mr.
Swanson was a partner with Kleiner Perkins Caufield & Byers, a venture capital partnership in San
Francisco. Mr. Swanson serves on the Board of Fellows of the Faculty of Medicine at Harvard
University and is a member of the Biology Visiting Committee of, and has served as a Trustee for, the
Massachusetts Institute of Technology. Mr. Swanson is a member of the Royal Swedish Academy of
Engineering Sciences and is a Director of Chemdex.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext